http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0304952-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f861d7dfdde7b233339d4838364a8e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate | 2003-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bffb5ab5d44ae77abe60665e63bf0b89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_970fcbc30244a9e99840709ff028b0d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dc0ae0f0f8c659988973645f9c8186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6ea61ba22af091e52d97868f47c399 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ff4bec34d79b3937c997940a04ea8b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52bdbcb0e4f6ef23fd3460ce5dddee9 |
| publicationDate | 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0304952-B1 |
| titleOfInvention | COMPOSITE PREPARATION PROCESS BETWEEN CYCLODEXTRINS AND ANTIMON DERIVATIVES OR PENTAVALENT ANTIMON, PRODUCTS, PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF LEISHMANIASIS AND SCHISOSOMOSIS AND USE. |
| abstract | "The process of preparing compounds between cyclodextrins or derivatives thereof and antimony or derivatives thereof, from pharmaceutical formulations containing such compounds and associated products for the treatment of leishmaniasis and schistosomiasis." The present invention relates to the preparation of compounds between cyclodextrins or derivatives and antimony or derivatives of pharmaceutical formulations from such compounds. The present invention is further characterized by increased oral, dermal and percutaneous absorption of antimony from such compounds and formulations. This increase in antimony bioavailability through these administration routes also characterizes therapeutic alternatives for the treatment of leishmaniasis and schistosomiasis orally and / or topically. |
| priorityDate | 2003-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.